Literature DB >> 11839112

The WHO Quality of Life (WHOQOL) Questionnaire: Danish validation study.

V Nørholm1, P Bech.   

Abstract

The objective of this pilot study was to evaluate the Danish translation of the WHO Quality of Life Questionnaire, the WHOQOL, by means of the psychometric properties of the Danish version. The translation method followed the WHO standard procedures, including forward and backward translation, focus group discussions, and assessment of response choice weighting through visual analogue scales. In the study we evaluated the applicability of the WHOQOL in patients with physical and mental disorders compared with a sample of healthy controls. The WHOQOL was compared with health-related quality of life questionnaire SF36 (Short Form 36). The internal consistency or homogeneity of the Danish WHOQOL was found adequate, and its applicability and its performance in distinguishing between population groups were satisfactory. The abbreviated version of WHOQOL-100, the WHOQOL-BREF, was analysed separately and was also found psychometrically valid. The WHOQOL is a questionnaire that is easy to administer, and it seems applicable for use.

Entities:  

Mesh:

Year:  2001        PMID: 11839112     DOI: 10.1080/080394801681019075

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  24 in total

1.  Quality of life among Iranian refugees resettled in Sweden.

Authors:  Mehdi Ghazinour; Jörg Richter; Martin Eisemann
Journal:  J Immigr Health       Date:  2004-04

2.  Drinking patterns, psychological distress and quality of life in a Norwegian general population-based sample.

Authors:  E F Mathiesen; S Nome; M Eisemann; J Richter
Journal:  Qual Life Res       Date:  2012-01-05       Impact factor: 4.147

3.  Content validity, construct validity, and reliability of the WHOQOL-Bref in a population of Dutch adult psychiatric outpatients.

Authors:  Fons J Trompenaars; Erik D Masthoff; Guus L Van Heck; Paul P Hodiamont; Jolanda De Vries
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

4.  Do the SF-36 and WHOQOL-BREF measure the same constructs? Evidence from the Taiwan population*.

Authors:  I-Chan Huang; Albert W Wu; Constantine Frangakis
Journal:  Qual Life Res       Date:  2006-02       Impact factor: 4.147

5.  Validating, improving reliability, and estimating correlation of the four subscales in the WHOQOL-BREF using multidimensional Rasch analysis.

Authors:  Wen-Chung Wang; Grace Yao; Yih-Jian Tsai; Jung-Der Wang; Ching-Lin Hsieh
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

6.  The suitability of the WHOQOL-BREF for Canadian and Norwegian older adults.

Authors:  Mary H Kalfoss; Gail Low; Anita E Molzahn
Journal:  Eur J Ageing       Date:  2008-02-13

7.  A controlled trial of internet-based cognitive-behavioural therapy for panic disorder with face-to-face support from a general practitioner or email support from a psychologist.

Authors:  Ciaran Pier; David W Austin; Britt Klein; Joanna Mitchell; Peter Schattner; Lisa Ciechomski; Kathryn J Gilson; David Pierce; Kerrie Shandley; Victoria Wade
Journal:  Ment Health Fam Med       Date:  2008-03

8.  Quality of life in the Danish general population--normative data and validity of WHOQOL-BREF using Rasch and item response theory models.

Authors:  V Noerholm; M Groenvold; T Watt; J B Bjorner; N A Rasmussen; P Bech
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

9.  Quality of life in mentally ill, physically ill and healthy individuals: the validation of the Greek version of the World Health Organization Quality of Life (WHOQOL-100) questionnaire.

Authors:  Maria Ginieri-Coccossis; Eugenia Triantafillou; Vlasis Tomaras; Ioannis A Liappas; George N Christodoulou; George N Papadimitriou
Journal:  Ann Gen Psychiatry       Date:  2009-10-13       Impact factor: 3.455

10.  Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression.

Authors:  Ulla Knorr; Maj Vinberg; Marianne Klose; Ulla Feldt-Rasmussen; Linda Hilsted; Anders Gade; Eva Haastrup; Olaf Paulson; Jørn Wetterslev; Christian Gluud; Ulrik Gether; Lars Kessing
Journal:  Trials       Date:  2009-08-11       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.